29 - MADWorld Ad

40 - Pharmatimes Awards

38 - AI

26-27

24 - Future Proof

13 - Connected Trials

39 - EHP Awards

2 Ad

4-5 Contents

September 2026

3 From the editor

25 EHP

This month's mag takes the relentless tittle-tattle from 'influencers' about GLP-1 before scrutinizing, deconstructing and refining it in a way only we can! In that spirit, we ask: where have all the risk takers gone, why isn't communication at the top table, and how do we make the most of data? As we bid farewell to a scorching summer, there's still time to focus on the future of clinical trials and how pharma can navigate an exponentially changing NHS.

Explore the latest PharmaTimes: cutting through the GLP-1 noise, the future of clinical trials, making the most of data, risk-taking and a changing NHS.

September 2026 - PharmaTimes Magazine

Summer's here and we're turning up the heat with another sizzling edition of PharmaTimes. Hot topics include how our industry plans to dance to the raving AI omni-beat, the unpredictable NHS climate and how transformation can steady the temperature, plus the hot-deskers at number 10 — including a certain A. Burnham. We also spotlight surging healthcare data usage, diversity in clinical trials, captivating comms, shifting recruitment sands and the latest GLP-1 forecast.  

Explore the summer edition of PharmaTimes: AI in pharma, NHS transformation, healthcare data, diversity in clinical trials and the latest GLP-1 forecast. Read pharma's premier publication today.

July 2026 - PharmaTimes Magazine

This issue reminds us that humankind remains the enduring question, and diversity in clinical trials is the answer (even if machine learning hops on for the ride!). We've also got features reflecting healthcare and society: health comms meets stand-up comedy, the chaos of probiotics, and medicine governance in focus. Plus a report on the PharmaTimes Clinical Researcher of the Year Awards, and the GLP-1 tour rolls on.

This month's PharmaTimes champions the human touch in healthcare, exploring diversity in clinical trials and the role of AI. Plus health comms, probiotics, medicine governance, GLP-1s, and the Clinical Researcher of the Year Awards.

June 2026 - PharmaTimes Magazine

This month’s curiously different PharmaTimes explores exciting new ecosystems across the life sciences. We examine the rise of health tech, the growing influence of Patient 2.0, and the reshaping of public health, putting the future into sharp focus. You'll also find laser-focused features on healthcare comms, the politics of health, lifecycle management, and the spectre of AI. Strap yourself in for an unforgettable ride with our industry’s premier publication!

This month’s PharmaTimes explores new life sciences ecosystems. Discover the future of health tech, Patient 2.0, and public health. Plus, laser-focused features on healthcare comms, health politics, lifecycle management, and the spectre of AI.

May 2026 - PharmaTimes Magazine

This month’s edition reimagines the NHS dichotomy as a dystopian game of Tetris - we investigate which parties might finally shake things up. We explore the GLP-1 explosion and how its boom will mold the medicines of the future. Plus, deep dives into AI in pharma, reproductive health in 2026, life sciences’ greatest hits, and the global impact of Trump’s healthcare decisions. Finally, comms guru Jess ‘Pharmery’ Farmery sparkles in her highly anticipated debut.

This month: the NHS as a dystopian game of Tetris, the GLP-1 explosion and its impact on future meds, plus deep dives into AI in pharma, reproductive health, and Trump’s healthcare influence. Also, comms guru Jess ‘Pharmery’ Farmery makes her debut!

April 2026 - PharmaTimes Magazine

PharmaTimes March edition ponders, wrestles and wonders at the present life sciences zeitgeist – what a time to be alive! As the cover boldly suggests, we are in an era of patient autonomy and, thus, a brave new landscape in which the population expect and deserve access to medicines. Features examine shifting politics, the rise of "super employees," and ongoing innovation. Articles cover GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI's relentless advance.

PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat cancers, top therapies of 2026, and AI's advance.

March 2026 - PharmaTimes Magazine

The New Year edition looks forward with vim, vigour and vision! 
We are, after all, in the midst of transformation. In drugs, through development, across trials and amid the melting both of digital and AI. It is – at once – exciting, curious and slightly imposing. 
In this edition we focus on all the aforementioned themes, and NHS turbulence, predictions for 2026, healthcare comms, the future of GLP-1s, online pharmacies, radiology progress, patient centricity 2.0 and more.

The New Year edition looks forward with vim, vigour and vision! We are, after all, in the midst of transformation. In drugs, through development, across trials and amid the melting both of digital and AI. It is exciting, curious and slightly imposing. 

January/February 2026 - PharmaTimes Magazine

The bells are ringing out for another spectacular Christmas edition of PharmaTimes. This year, we recline and reflect on a transformative year across the pharmaverse, with wistful reminiscences from our panel of industry gurus. There is also plenty to unwrap from the NHS, as we explore how pharma will be breaking bread with public health in the months ahead. 

December 2025 - PharmaTimes Magazine

In this edition we dare to dream – fever dream, no less – about the future of the NHS. We go beyond the current chaos and speculate about the possibilities built on the founding principles, but without any of the peeling paint and dated equipment. There are also features that focus on the conditions of our times – MND, mental health and even the very skin we live in.

November 2025 - PharmaTimes Magazine

As an occupation at the very epicentre of healthcare, the nurse is a constant and iconic presence. In this edition of PharmaTimes, we demonstrate how this reassuring and essential presence within our industry's ecosystem continues to evolve. Talking of evolution, we will also fearlessly segway into the all-encompassing era of AI. Once a vague conversation, but now an often inspiring but slightly daunting reality, the robots are here to stay! In addition, we check out pharmacovigilance, dissect Keir Starmer, explore clinical trial data, peruse patient access and much, much more!

October 2025 - PharmaTimes Magazine

The new era of pharma is not just here – we are living through it. Our latest issue is about progress, getting there and arriving.

September 2025 - PharmaTimes Magazine

In this bold edition we talk about weight loss drugs – are they healthcare products, an NHS saviour or a complex cosmetic project? We also follow the astonishing and seemingly unstoppable acceleration of AI and the instant impact it is having on industry marketing, the use of data and humankind itself. Features on future innovation, decoding Parkinson’s disease, pharmacovigilance, the link between animal and public health, a review of our International Clinical Researcher of the Year Awards and what decisions must be made about the NHS, complete a tubthumping edition of pharma’s most intrepid periodical.

July/August 2025 - PharmaTimes Magazine

Issues

Online Media Hub

PharmaTimes Magazine

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

https://pharmatimes.com/

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes

PharmaTimes

Categories

Social Footprints